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Background: Insulin/IGF-1 signaling plays a central role in longevity across phylogeny. In C. elegans, the forkhead
box O (FOXO) transcription factor, DAF-16, is the primary target of insulin/IGF-1 signaling, and multiple isoforms of
DAF-16 (a, b, and d/f) modulate lifespan, metabolism, dauer formation, and stress resistance. Thus far, across phylogeny
modulation of mammalian FOXOs and DAF-16 have focused on post-translational regulation with little focus on
transcriptional regulation. In C. elegans, we have previously shown that DAF-16d/f cooperates with DAF-16a to
promote longevity. In this study, we generated transgenic strains expressing near-endogenous levels of either
daf-16a or daf-16d/f, and examined temporal expression of the isoforms to further define how these isoforms
contribute to lifespan regulation.
Results: Here, we show that DAF-16a is sensitive both to changes in gene dosage and to alterations in the level
of insulin/IGF-1 signaling. Interestingly, we find that as worms age, the intestinal expression of daf-16d/f but not
daf-16a is dramatically upregulated at the level of transcription. Preventing this transcriptional upregulation
shortens lifespan, indicating that transcriptional regulation of daf-16d/f promotes longevity. In an RNAi screen of
transcriptional regulators, we identify elt-2 (GATA transcription factor) and swsn-1 (core subunit of SWI/SNF complex) as
key modulators of daf-16d/f gene expression. ELT-2 and another GATA factor, ELT-4, promote longevity via both
DAF-16a and DAF-16d/f while the components of SWI/SNF complex promote longevity specifically via DAF-16d/f.
Conclusions: Our findings indicate that transcriptional control of C. elegans FOXO/daf-16 is an essential regulatory
event. Considering the conservation of FOXO across species, our findings identify a new layer of FOXO regulation as a
potential determinant of mammalian longevity and age-related diseases such as cancer and diabetes.
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The evolutionarily conserved insulin/IGF-1 signaling (IIS)
pathway regulates lifespan from worms to mammals and in
C. elegans also modulates dauer formation, stress response,
and metabolism [1-4]. The C. elegans IIS pathway consists
of an insulin/IGF-1 receptor (DAF-2) [5], a PI 3-kinase
(AGE-1/AAP-1) [6,7] serine/threonine kinases (PDK-1,
AKT-1, and AKT-2) [8,9], and a Forkhead Box O (FOXO)
transcription factor (DAF-16) [10,11]. IIS ultimately results* Correspondence: heidi.tissenbaum@umassmed.edu
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unless otherwise stated.in the AKT-dependent phosphorylation of DAF-16,
thereby preventing DAF-16 from entering the nucleus
to regulate its target genes [3,4,12]. Therefore, the C.
elegans FOXO ortholog, DAF-16 is the primary down-
stream target of the IIS pathway [10,11].
In contrast to C. elegans, mammals have three closely
related FOXO proteins (FOXO1, FOXO3, and FOXO4)
that share a high degree of homology, overlapping ex-
pression patterns, and common target genes [13,14].
These FOXOs appear to have discrete functions as each
mutant displays a distinct phenotype: Foxo1 null mice
die as embryos due to defects in angiogenesis [15],
Foxo3 mutants are viable but show age-dependent fe-
male sterility [15,16], and Foxo4 null mutants are viable
with no detectable phenotype [15]. Interestingly, condi-
tional somatic deletion of all three Foxo loci results in aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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thymic cancers and hemangiomas, indicating that Foxo1,
Foxo3, and Foxo4 are redundant tumor suppressor genes
specifically involved in endothelial growth suppression
[17]. Recently, a more distantly related FOXO family
member, FOXO6, was shown to regulate gluconeogene-
sis [18]. Thus, four mammalian FOXO homologs play
distinct and overlapping roles in multiple biological
processes.
DAF-16, the only C. elegans FOXO ortholog, expresses
multiple isoforms (Figure 1). Initial studies on DAF-16
identified three different transcripts, daf-16a1, daf-16a2,
and daf-16b. daf-16a1 and daf-16a2 share the same pro-
moter and 11 exons, but alternative splicing at exon 3
results in an insertion of two additional amino acids in
the DAF-16a1 protein compared to DAF-16a2 [19,20].
daf-16b encodes a shorter isoform, expressed from a dif-
ferent promoter and results in a protein that includes
the same C-terminal 319 amino acids as the DAF-16a1/a2
isoforms. Recently, we identified a third DAF-16 isoform,
daf-16d/f, which is driven by a distinct promoter and initi-
ates approximately 10 kb upstream of daf-16a1/a2. daf-
16d/f is encoded by 14 exons, 10 of which are shared
with DAF-16a1/a2 and DAF-16b. Studies using isoform-
specific RNAi and transgenes have revealed cooperative as
well as specific functions for these three DAF-16 isoforms
(DAF-16a, DAF-16b, and DAF-16d/f) in the regulation of
lifespan, dauer formation, fat storage, and stress resistance
[21]. For lifespan regulation, however, we found that only
DAF-16a and DAF-16d/f are involved [21]. The relative
contribution of each of these two isoforms and regulation
of each isoform remains unknown.
To date, much has been learned about the post-
translational regulation of FOXO/DAF-16. For example,
FOXO/DAF-16 is directly phosphorylated by kinases in-
cluding AKT-1, AKT-2, SGK-1, Jun-N-terminal kinase
(JNK/JNK-1) [22-24], Ste20-like protein kinase (MST1/
CST-1) [25], and AMP-activated protein kinase (AMPK/
AAK-1) [26,27], and FOXO/DAF-16 interacts with a Serine/
threonine-protein phosphatase 4 regulatory subunit, SMK-1
[28]. FOXO/DAF-16 also interacts with 14-3-3 proteins,
which modulate the ability of FOXO/DAF-16 to inter-
act with cofactors, including the sirtuin family (SIRT1/
SIR-2.1) of NAD-dependent deacetylases [3,4,29,30].Figure 1 Structure of daf-16 isoforms. Coding regions are orange-filled
with a green line. The SL1 trans-spliced reads for the different isoforms are:
See Additional file 1: Table S1 for ESTs associated with the different isoforms.These interactions and direct post-translational modi-
fications function to modulate the activity of FOXO/
DAF-16 under different conditions [3,4].
Despite the growing body of knowledge centered on
the post-translational regulation of FOXO/DAF-16, little
is known about the transcriptional regulation of daf-16
in C. elegans. To begin to address these issues, we exam-
ined the expression of the daf-16a and daf-16d/f iso-
forms throughout development and adulthood. We found
that daf-16d/f expression is dramatically increased at the
level of transcription during the young adult stage, and
this upregulation of daf-16d/f expression is required for
longevity. Furthermore, using an RNAi screen we identi-
fied two transcriptional regulators of daf-16d/f expression:
elt-2, encoding an essential GATA transcription factor re-
quired for intestinal development [31,32], and swsn-1, en-
coding a core component of the SWI/SNF chromatin
remodeling complex [33,34]. ELT-2 and another GATA
factor, ELT-4, are required for the expression of both daf-
16a and daf-16d/f and for the ability of both daf-16a and
daf-16d/f to promote longevity. By contrast, SWSN-1 and
other SWI/SNF components are required for the upregu-
lation of daf-16d/f expression in the intestine of young
adults, but not daf-16a expression. Consistent with this
finding, components of the SWI/SNF complex promote
longevity via daf-16d/f but not daf-16a. Taken together,
our findings reveal that transcriptional regulation of
daf-16d/f is an important regulatory event in lifespan
determination.
Results and discussion
daf-16 has multiple isoforms
daf-16 functions as a central regulator of multiple bio-
logical processes including lifespan, development, fat stor-
age, and stress resistance [1-4]. The C. elegans genome
resource, Wormbase (http://www.wormbase.org), predicts
eight putative isoforms of daf-16, with each isoform desig-
nated by a lowercase letter following the cosmid name for
daf-16 (R13H8.1a-h). To verify expression of the daf-16
isoforms, we first analyzed the Gurdon Institute C. elegans
expressed sequence tag (EST) database (http://genomics.
nimr.mrc.ac.uk/online/worm-fl-db.html) [35,36]. As shown
in Additional file 1: Table S1, ESTs were identified that
map to daf-16f (R13H8.1f), daf-16d (R13H8.1d), daf-16aboxes, and introns are lines. The SL1 trans-spliced region is indicated
daf-16d/f, 8 reads; daf-16d, 9 reads; daf-16a, 208 reads; daf-16b, 14 reads.
Figure 2 Effects of altering DAF-16a dosage on lifespan. (A)
Expression levels of daf-16a mRNA in various daf-16(mgDf50); daf-2
(e1370); daf-16a::gfp strains were compared to that of daf-2(e1370)
worms. The graph is plotted on a log2 scale. Error bars represent
standard deviation (S.D.) from two independent repeats. Statistical
values are given in Additional file 1: Table S2. (B) Lifespan of daf-16
(mgDf50) worms carrying various daf-16a::gfp transgenes as well as
low-copy daf-16d/f::gfpHT. Three high-copy daf-16a transgenic worms
live longer than wild type. daf-16a::gfpHT worms lived shorter than
wild-type, while the lifespan of the daf-16d/f::gfpHT strain is comparable
to wild type. (C) Lifespan of daf-16(mgDf50); daf-2(e1370) worms carrying
various daf-16::gfp transgenes. daf-16a::gfpHT worms lived shorter than
the daf-2(e1370) mutants. daf-16(mgDf50); daf-2(e1370); daf-16a::gfpGR
worms had the shortest lifespan among the high-copy daf-16a
transgenic strains. daf-16d/f::gfpHT transgene alone fully rescued
the lifespan extension of daf-2(e1370) mutants. One lifespan experiment
is shown from a total of three repeats; each with similar results. All lifespan
data are shown in Additional file 1: Table S3.
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ESTs, we examined published capped RNA (Cap-Seq)
(Gu et al. [37]), total mRNA, and ribosome-associated
mRNA deep sequencing datasets (Stadler et al. [38]).
These datasets support the existence of daf-16f, daf-
16d, daf-16a1, daf-16a2, and daf-16b. In particular,
the Cap-Seq data specifically identified four spliced
leader (SL1) sites corresponding to the capped 5’ ends
of daf-16f, daf-16d, daf-16a1/a2, and daf-16b, as indi-
cated in green in Figure 1. Therefore, our findings ver-
ify the existence of five isoforms in contrast to eight
that were predicted initially for DAF-16 - (DAF-f (R13H8.1f),
DAF-16d (R13H8.1d), DAF-16a1 (R13H8.1b), DAF-16a2
(R13H8.1c), and DAF-16b (R13H81.a).
Previous RNAi and transgenic studies examined the
function of different daf-16 isoforms (daf-16a, b, d/f )
[19-21], which revealed that daf-16b functions in dauer
formation, while daf-16a and daf-16d/f contribute to
lifespan regulation. According to our previous studies
[21], daf-16a constructs could not rescue the lifespan
phenotype of a complete loss of daf-16, and daf-16d
transgenes were unstable and did not consistently rescue
daf-16 loss-of-function. However, transgenes expressing
the daf-16f isoform or daf-16d/f showed similar expres-
sion patterns and consistently rescued the complete loss
of daf-16 [21] (Figure 2). Moreover, based on the Cap-
Seq data, both daf-16f and daf-16d have the same tran-
scription start site. Therefore, we continue to refer to
these isoforms as daf-16d/f in this study.
Effects of altering DAF-16a dosage on lifespan
Dissecting the relative contributions of DAF-16d/f and
DAF-16a in the regulation of longevity has been challen-
ging due to incomplete knockdown by isoform-specific
RNAi [21] and the lack of isoform-specific mutants. This
is further complicated by the existence of a dose-dependent
effect of daf-16a and daf-16d/f transgenes [21]. To expand
our analysis of the daf-16 dosage effect on lifespan, we first
generated a new low-copy daf-16a transgene by micropar-
ticle bombardment, which we refer to as daf-16a:gfpHT. In
addition, we chose three commonly used high-copy daf-
16a transgenes, referred to as daf-16a::gfpCF derived from
strain CF1407 [20], daf-16a::gfpTJ from TJ356 [39], and
daf-16a::gfpGR from RX86 [40]. For all the analyses that fol-
low, we first placed each daf-16 transgene into the same
genetic background which is a null allele of the endogenous
daf-16 locus [daf-16(mgDf50)].
To compare the levels of daf-16a in the different
transgenic strains, we measured the level of daf-16a ex-
pression from each transgene in the daf-16(mgDf50);
daf-2(e1370) background and compared it to the endogen-
ous level of daf-16a in daf-2(e1370) mutants (Figure 2A,
Additional file 1: Table S2). The level of daf-16a expressed
from the newly generated daf-16aHT transgenic strain was
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16a in the daf-2(e1370) mutant, while the commonly used
daf-16a transgenes were expressed at 10- to 400-fold
higher levels than endogenous daf-16a. These results
show the following order for levels of the daf-16a tran-
script: endogenous daf-16a <HT <CF <TJ < < GR. Con-
sistent with the mRNA expression data, the level of
DAF-16a protein from the transgenic strains also in-
creases (Additional file 1: Figure S1). The GFP inten-
sity in the four transgenic strains correlated with the
level of expression of DAF-16a (data not shown).
Next, we determined the nuclear:cytosolic ratio of
DAF-16a in the transgenic strains expressing different
levels of DAF-16a (Additional file 1: Figure S2) in daf-2
(e1370) background. DAF-16a was almost entirely in the
nucleus when expressed at low levels from the daf-16a::
gfpHT transgene. By contrast, DAF-16a was mainly cyto-
solic in the daf-2(e1370); daf-16aGR strain, which shows
the highest level of DAF-16a expression, while the daf-2
(e1370); daf-16a::gfpCF and daf-2(e1370); daf-16a::gfpTJ
strains showed an intermediate nuclear localization of
DAF-16a. Importantly, since these different transgenic
strains were generated with different methods and may
be integrated at different locations, this indicates that it
is the level of mRNA and protein of DAF-16a that deter-
mines its regulatory ability.
We reasoned that if a daf-16a transgene is expressed
at close to endogenous levels, the daf-16a transgenic an-
imals should not live longer than wild-type animals ex-
pressing endogenous levels of all three DAF-16 isoforms.
Interestingly, our low-copy daf-16a::gfpHT transgenic worms
lived shorter than wild-type (Figure 2B, Additional file 1:
Table S3), suggesting that low level expression of daf-16a
alone cannot replace loss of the endogenous daf-16 for life-
span regulation. However, the three high-copy daf-16a
transgenic strains lived longer than wild type (Figure 2B,
Additional file 1: Table S3). Therefore, these data suggest
that the level of DAF-16a expressed from the daf-16a::
gfpCF, daf-16a::gfpTJ, and daf-16a::gfpGR transgenes ex-
ceeds the inhibitory capacity of the IIS pathway. This gene
dosage effect was even more pronounced when each daf-
16a transgene was analyzed in the daf-16(mgDf50); daf-2
(e1370) double mutant background (Figure 2C, Additional
file 1: Table S3). As shown in Figure 2B and consistent
with previous findings [19-21], when expressed at low
levels from a daf-16a::gfpHT transgene, DAF-16a cannot
fully compensate for a complete loss of DAF-16 function
(Figure 2B) [21]. An increase in lifespan was observed with
increased expression of DAF-16a (daf-16a::gfpCF, daf-16a::
gfpTJ). However, as the dosage of DAF-16a continued to
increase (for example, daf-16a::gfpGR), a reduction in life-
span was seen (Figure 2C, Additional file 1: Table S3).
Consistent with this finding, unlike the other daf-16a trans-
genic strains, the daf-16a::gfpGR showed severely delayeddevelopment and reduced fecundity, suggesting that ex-
tremely high levels of DAF-16a are toxic (Additional file 1:
Figure S3). Together, these findings suggest that the three
commonly used strains for analyses of DAF-16:GFP do not
accurately reflect the endogenous function of DAF-16a in
lifespan regulation. Furthermore, these results indicate that
low-copy daf-16a strains are more relevant for functional
analyses as well as for DAF-16 localization assays (Additional
file 1: Figures S2).
Next, we examined the low-copy daf-16d/f::gfpHT
transgene [21], which had approximately four-fold
higher transcript level than endogenous daf-16d/f levels
in the daf-2(e1370) mutant background (Additional
file 1: Table S2). Unlike high-copy daf-16a and daf-
16d/f transgenic worms [21], these daf-16(mgDf50);
daf-16d/f::gfpHT transgenic worms did not live longer
than wild-type (Figure 2B, Additional file 1: Table S3),
suggesting that DAF-16d/f activity in the low-copy
daf-16d/f transgenic strain is regulated within the in-
hibitory capacity of the IIS pathway. Even though the
strains were generated by different methods, we sug-
gest that it is the level of the DAF-16 isoform protein
that leads to an environment that does not accurately
reflect endogenous levels of DAF-16.
DAF-16d/f and DAF-16a respond differently to changes in
IIS
The low-copy daf-16 isoform transgenes were crossed
into the background of another widely used daf-2 allele,
daf-2(e1368), which exhibits weaker longevity and dauer
arrest phenotypes than daf-2(e1370) [5,41]. Based on our
lifespan data in the daf-16(mgDf50); daf-2(e1370) back-
ground, we expected that the daf-16d/f::gfpHT transgene
would be sufficient to fully complement the lifespan of a
daf-16(mgDf50); daf-2(e1368) double mutant. Yet, to our
surprise, daf-16(mgDf50); daf-2(e1368); daf-16d/f::gfpHT
transgenic worms lived significantly shorter than the
daf-2(e1368) single mutant (Figure 3A, Additional file 1:
Figure S4, Additional file 1: Table S3, Additional file 1:
Table S4). In contrast, the daf-16a::gfpHT transgene res-
cued lifespan to similar levels in both daf-2(e1368) and
daf-2(e1370) mutant backgrounds (Additional file 1:
Figure S4, Additional file 1: Table S3, Additional file 1:
Table S4).
To further test the effect of DAF-16d/f in the daf-2
(e1370) and daf-2(e1368) mutant backgrounds, we exam-
ined dauer formation as an additional output of DAF-16
activity. At the restrictive temperature of 25°C, both daf-2
(e1370) and daf-2(1368) form 100% dauers whereas daf-16
(mgDf50); daf-2(e1370) and daf-16(mgDf50); daf-2(e1368)
double mutants do not form any dauers. However, once
again, the DAF-16d/f transgene had different effects
in the two daf-2 alleles: daf-16(mgDf50); daf-2(e1368);
daf-16d/f::gfpHT transgenic worms formed approximately
Figure 3 DAF-16d/f and DAF-16a respond differently to changes in insulin/IGF-1 signaling. (A) Lifespan analysis of daf-16(mgDf50); daf-2
(e1368) worms carrying daf-16a::gfpHT or daf-16d/f::gfpHT. One of three repeats is shown; each with similar results. All of the lifespan data are
shown in Additional file 1: Table S4. (B) Dauer formation in daf-16(mgDf50); daf-2(e1370) or daf-16(mgDf50); daf-2(e1368) worms carrying daf-16a::
gfpHT or daf-16d/f::gfpHT at 20°C. The daf-16(mgDf50); daf-2(e1368); daf-16d/f strain did not form dauers, while daf-16(mgDf50); daf-2(e1370); daf-16d/
f strain formed a significant fraction of dauers. Dauer formation data represents one experiment with additional repeats showing similar results
(Additional file 1: Figure S5). (C) Localization of DAF-16 isoforms in daf-2(e1368) and daf-2(e1370) mutant backgrounds. daf-16(mgDf50); daf-2
(e1368) or daf-16(mgDf50); daf-2(e1368) worms carrying daf-16a::gfpHT or daf-16d/f::gfpHT, as well as the daf-2 mutants expressing endogenous
daf-16 isoforms, were visualized after incubation at 20°C for 20 hours. Red arrows indicate nuclear DAF-16. (D) Quantification of the nuclear
localization of the DAF-16 isoforms in daf-2(e1368) and daf-2(e1370) mutant backgrounds. Nuclear enrichment of DAF-16d/f is observed in
daf-2(e1370) worms but not in daf-2(e1368) worms, while nuclear enrichment of DAF-16a is observed in both daf-2 alleles.
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16d/f::gfpHT worms formed approximately 98% dauers
at 25°C (Additional file 1: Figure S5A). At the semi-
permissive temperature of 20°C, a similar trend was ob-
served. This is in contrast to daf-16a transgenic worms
where dauer formation was comparable in both daf-2 mu-
tant backgrounds (Figure 3B, Additional file 1: Figure S5).
Examining the DAF-16 nuclear/cytosolic localization,
DAF-16d/f was enriched in the nucleus in the daf-2
(e1370) background, but more cytosolic in the daf-2
(e1368) background (Figure 3C,D). In contrast, DAF-16a
was primarily enriched in the nucleus in both daf-2
(e1368) and daf-2(e1370) backgrounds (Figure 3C,D).
Thus, the DAF-16 localization data correlated with both
functional outputs - lifespan and dauer formation. Whereas
DAF-16a is activated to a similar level in both alleles, DAF-
16d/f is less active in the daf-2(e1368) mutant than in the
daf-2(e1370) mutant. Therefore, these data show that DAF-
16a and DAF-16d/f exhibit different thresholds for inhib-
ition by the upstream IIS pathway.
Transcription of daf-16d/f is upregulated during aging
Although the spatial expression patterns of daf-16 have
been extensively investigated [19,20,39], the temporalexpression of daf-16 has not been studied. We moni-
tored the expression of the daf-16 isoform::gfp strains
throughout development and for the first few days of
adulthood. Interestingly, as shown in Additional file 1:
Figure S6, the GFP intensity of the daf-16d/f::gfp trans-
genic worms dramatically increased in the adult stage
compared to larval stages.
Next, we asked if the increase in GFP intensity in adult
daf-16d/f::gfp transgenic animals correlates with the level
of the endogenous transcript. Using qRT-PCR, we found
that each of the daf-16 isoforms was expressed at a con-
stant level throughout larval development. However, as
worms aged, the daf-16d/f transcript dramatically in-
creased in both wild-type and long-lived daf-2(e1370) mu-
tants, while the daf-16a transcript increased only slightly
(Figure 4A,B, Additional file 1: Figure S7-S9). To further
confirm this result, we tested the upregulation of DAF-
16a vs DAF-16d/f at the protein level. Since it is not pos-
sible to distinguish differences in endogenous levels of
DAF-16a and DAF-16d/f protein, we were limited to
examining changes in DAF-16 protein levels in strains
that only bear one DAF-16 isoform (daf-2;daf-16;daf-16a::
gfp or daf-2;daf-16;daf-16d/f::gfp). Using these transgenic
strains, consistent with our mRNA data, the age-dependent
Figure 4 daf-16d/f is regulated at the level of transcription in both a temporal and spatial manner. (A,B) Quantitative RT-PCR analysis of
endogenous daf-16a and daf-16d/f mRNA levels during larval development (L1-L4) and in the adult. In both wild-type and daf-2(e1370) mutants,
the level of daf-16d/f mRNA significantly increases with age. Additional details are shown in Additional file 1: Figure S7. (C,D) Changes in DAF-16d/f
and DAF-16a protein levels with age. Equal volumes of worms were used for each larval stage. Western blots with the worm lysates were probed with
anti-α-DAF-16 antibody (top panel) and anti-α-tubulin (bottom panel). DAF-16d/f shows a dramatic increase in protein levels with age as compared to
DAF-16a. (E) Quantification of the fluorescence intensity in Pdaf-16a::gfp and Pdaf-16d/f::gfp transgenic worms as they age The GFP intensity was
quantified using ImageJ software and normalized to the L1 stage for each strain. (F) Transcriptional regulation of daf-16d/f determines longevity.
daf-16(mgDf50); daf-2(e1370); daf-16d/f transgenic worms were treated with diluted daf-16 RNAi bacteria from the L4 stage to day 2 adulthood. All
lifespan data are shown in Additional file 1: Table S5.
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the protein level (Figure 4C,D).
The qRT-PCR assay is a read-out of the steady-state
level of mRNA, but the DAF-16::GFP fusion fluores-
cence is the product of both transcriptional and post-
transcriptional regulation. Therefore, to measure the tran-
scriptional promoter activity of each daf-16 isoform, we
generated daf-16 promoter::GFP fusions (Pdaf-16::gfp).
The promoter of each daf-16 isoform was placed up-
stream of the GFP open reading frame fused to the unc-54
3′UTR, which is known to be absent of temporal regula-
tory elements [42]. We reasoned that if increased tran-
scription is responsible for the elevated mRNA level in
young adults, then the GFP intensity should becomebrighter in the promoter::gfp transgenic worms as the
worms age. In the Pdaf-16a::gfp worms, the GFP signal
throughout the body increased slightly with age. In con-
trast, in Pdaf-16d/f::gfp worms, GFP expression increased
dramatically throughout the intestine (data not shown
Figure 4E). Therefore, across multiple independent ex-
periments we found that transcription of daf-16, par-
ticularly daf-16d/f, was regulated in an age-dependent
manner.
daf-16d/f transcript level in the early adult determines
lifespan
daf-16 expression in the intestine is critical for lifespan
regulation in C. elegans [21,43], and our temporal and
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dramatically upregulated in the intestine as worms age.
To determine the importance of DAF-16 upregulation in
aging worms, we used RNAi to maintain daf-16d/f ex-
pression in the adult stage at a level comparable to that
in the L4 stage, thereby preventing the upregulation of
DAF-16d/f during aging. To achieve the correct knock-
down level, we prepared serial-dilutions of daf-16 RNAi
bacteria (from no dilution to 64-fold dilution) and fed
daf-16(mgDf50); daf-2(e1370); daf-16d/f::gfpHT worms
from the L4 stage to day 2 adults. After 2 days of growth
on the daf-16 RNAi plates, worms were transferred to
control RNAi plates. We found that worms grown on
four-fold to 16-fold diluted daf-16 RNAi bacteria main-
tained daf-16d/f expression at levels similar to that of
the L4 worms (Additional file 1: Figure S10). Import-
antly, the lifespan of daf-16(mgDf50); daf-2(e1370); daf-
16d/f::gfpHT worms fed on the four-fold to 16-fold di-
luted daf-16 RNAi bacteria was reduced as compared to
animals grown on control bacteria (Figure 4F, Additional
file 1: Table S5). Therefore, the upregulation of daf-16d/f
gene expression at the young adult stage is an important
determinant of C. elegans lifespan.
The ELT-2 transcription factor promote longevity by
regulating both daf-16a and daf-16d/f expression
Our findings suggest that transcriptional regulators
expressed in the intestine activate daf-16d/f transcription
in an age-dependent manner. To identify regulator(s) of
daf-16d/f gene expression, we performed an RNAi screen
of 892 transcriptional regulators using Pdaf-16d/f::gfp
transgenic worms. RNAi of two transcriptional regulators
reduced Pdaf-16d/f::gfp expression: elt-2, a GATA tran-
scription factor; and swsn-1, a core component of the
SWI/SNF chromatin remodeling complex (Figure 5A,
B,C). elt-2 is essential for intestinal development
[31,32,44,45] as well as innate immune responses to
bacterial and fungal infection [46] and directly regu-
lates the expression of >80% of intestinal genes, including
genes that are downstream of daf-16 (dod gene) [32].
Because worms fed with elt-2 RNAi from hatching de-
velop an abnormal intestinal structure and die within a
few days, we used post-developmental RNAi to silence
elt-2 beginning at the L4 stage when intestinal development
is complete. Indeed, post-developmental elt-2 RNAi treat-
ment also reduced Pdaf-16d/f::gfp expression (Figure 5B).
When we examined the endogenous daf-16 transcripts, we
found that post-developmental elt-2 RNAi treatment re-
duced the expression of endogenous daf-16d/f compared to
control RNAi (Figure 5C). In contrast, the Pdaf-16a::gfp was
only marginally downregulated on elt-2 RNAi at day 2 and
endogenous daf-16a expression was not changed, likely due
to the fact that its intestinal expression is only a minor por-
tion of total daf-16a (Additional file 1: Figure S11) [21].Accordingly and consistent with a recent report [47], elt-2
RNAi reduced the lifespan of the daf-2(e1370) single mutant
(expressing endogenous daf-16), as well as daf-16(mgDf50);
daf-2(e1370); daf-16a::gfpHT and daf-16(mgDf50); daf-2
(e1370); daf-16d/f::gfpHT transgenic worms (Figure 6A,
C, D, Additional file 1: Table S6). Relative to the con-
trol RNAi, elt-2 RNAi did not shorten the lifespan of a
daf-16(mgDf50); daf-2(e1370) mutant (Figure 6B), sug-
gesting that elt-2 RNAi shortens lifespan by reducing
intestinal daf-16 gene expression and not by a daf-16-
independent pathway.
We analyzed several additional GATA transcription
factors for a role in daf-16 transcriptional regulation and
longevity, including elt-4 and elt-7, which are expressed
in the intestine [44], and elt-3, elt-5, and elt-6, which
were previously implicated in lifespan regulation [48].
Only elt-4 RNAi reduced the expression of the Pdaf-
16d/f::gfp transcriptional reporter (Additional file 1:
Figure S13), though less dramatically than elt-2 RNAi.
Furthermore, only elt-4 RNAi reduced the lifespan of
both daf-16(mgDf50); daf-2(e1370); daf-16a::gfpHT and
daf-16(mgDf50); daf-2(e1370); daf-16d/f::gfpHT trans-
genic worms (Figure 6E–H, Additional file 1: Table S6).
Neither Pdaf-16d/f::gfp expression nor lifespan was af-
fected by elt-7, elt-3, elt-5, or elt-6 RNAi (Additional file 1:
Figure S13 and Additional file 1: Table S6). These data are
consistent with a recent study [49] suggesting that the
previously reported role of ELT-3 in lifespan regulation
[48] should be re-evaluated. Our findings indicate that the
ELT-2 and ELT-4 GATA factors promote longevity by
regulating intestinal daf-16 expression.
SWI/SNF determines lifespan by regulating daf-16d/f
expression
The second positive clone we obtained from our screen
was swsn-1, which encodes a core component of the
highly conserved SWI/SNF nucleosome-remodeling com-
plex [50]. In C. elegans, SWI/SNF is required for asymmet-
ric cell division [51] and differentiation [52]. Prior to the L4
stage, Pdaf-16d/f::gfp expression was unaffected by swsn-1
RNAi (Figure 5A,B). In adult worms, however, the upregu-
lation of GFP in the mid-intestine is severely reduced by
swsn-1 RNAi (Figure 5B). Expression of endogenous daf-
16d/f was also reduced in animals exposed to swsn-1 RNAi
(Figure 5C, Additional file 1: Figure S12B). Interestingly,
swsn-1 RNAi did not significantly change the expression of
Pdaf-16a::gfp (Additional file 1: Figure S11C), suggesting
that SWSN-1 regulates the temporal and spatial expression
of daf-16d/f, specifically. RNAi targeting snfc-5 and swsn-
2.1, core and accessory subunits of SWI/SNF, respectively,
also reduced the temporal upregulation of daf-16d/f ex-
pression with age (Additional file 1: Figure S12) but did not
change daf-16a expression, indicating that the SWI/SNF
complex specifically controls daf-16d/f expression.
Figure 5 ELT-2 and SWSN-1 are required for daf-16 gene expression. (A) Pdaf-16d/f::gfp expression grown on control, elt-2 RNAi or swsn-1
RNAi bacteria. Left and middle panels worms grown on RNAi from hatching, right panel worms grown on RNAi from L4. Red arrows indicate the
head region of the worms. (B) Close-up of worms shown in Panel A Left and middle columns with additional GFP RNAi control. Pdaf-16d/f::gfp
expression in the head and anterior intestine of worms grown on control, gfp, elt-2, or swsn-1 RNAi bacteria from hatching. (C) Quantitative
RT-PCR analysis of endogenous daf-16d/f in L4 larvae and Days 1, 2, and 5 adult daf-2(e1370) worms. For elt-2, worms were grown on RNAi
bacteria from L4 stage and for swsn-1 were grown on RNAi bacteria from hatching. The expression of daf-16d/f is reduced by elt-2 or swsn-1
RNAi treatment. Additional details are shown in Additional file 1: Figure S13.
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regulation. Both swsn-1 and snfc-5 are essential genes
[51] and hatched larvae grown on swsn-1 or snfc-5 RNAi
develop into sick adults with pleiotropic defects [51,53].
To avoid these complications in lifespan analysis, we
used post-developmental (L4) RNAi to silence swsn-1.
However, Pdaf-16d/f::gfp expression was largely unaffected
by post-developmental swsn-1 RNAi (data not shown) andwe observed only a marginal reduction of lifespan in daf-16
(mgDf50); daf-2(e1370); daf-16d/f::gfpHT transgenic worms
(Figure 6D, Additional file 1: Table S6), suggesting that
post-developmental (L4) RNAi does not efficiently silence
swsn-1. Worms exposed to swsn-2.1 RNAi from hatching,
however, were much healthier than animals grown on
swsn-1 or snfc-5 RNAi, which allowed us to assess the effect
of SWI/SNF on lifespan. As shown in Figure 6H and
Figure 6 ELT-2, ELT-4, and SWI/SNF promote longevity by regulating daf-16 gene expression. (A-D) elt-2 and swsn-1 RNAi were started at
the L4 stage. (E-H) elt-4 and swsn-2.1 RNAi were started at the L1 stage (hatching). Lifespan analyses of daf-2(e1370) (A, E), daf-16(mgDf50); daf-2
(e1370) (B, F), daf-16(mgDf50); daf-2(e1370); daf-16a::gfp (C, G), and daf-16(mgDf50); daf-2(e1370); daf-16d/f::gfp (D, H). One of three repeats is
shown; each with similar results. All lifespan data are summarized in Additional file 1: Table S6.
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lifespan of daf-16(mgDf50); daf-2(e1370); daf-16d/f::gfpHT
worms, but only modestly reduced the lifespan of daf-2
(e1370) or daf-16(mgDf50); daf-2(e1370); daf-16a::gfpHT an-
imals (Figure 6F,G, Additional file 1: Table S6). Interest-
ingly, a very recent paper found that SWI/SNF interacts
with DAF-16 [54]. These studies revealed that a SWI/SNF-
DAF-16 complex co-localizes at the promoters of DAF-16
direct targets and activates genes important for lifespan,
dauer formation, and stress resistance [54]. Therefore, these
results support a biochemical interaction of DAF-16 and
SWI/SNF. Taken together, our data are consistent with a
model in which the SWI/SNF complex directly interacts
with DAF-16 to specifically promote longevity by regulating
daf-16d/f expression.Conclusion
In C. elegans, the single FOXO family member, DAF-16
regulates lifespan, metabolism, development, and stress
resistance by generating multiple isoforms including
DAF-16d/f, DAF-16a, and DAF-16b [21]. Comparing the
relative abundances of the different isoforms revealed
that daf-16d/f is the most abundant isoform in early
adulthood and that transcription of daf-16d/f mRNA is
dramatically increased in the intestine as animals age.
These findings are in agreement with previous studies
showing that DAF-16 expression in the intestine is im-
portant for lifespan regulation and that lifespan is deter-
mined in adulthood [43,55]. Therefore, the temporal
control of daf-16d/f transcription in the intestine is a
critical determinant of longevity.
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is conserved in mammals. In rats, FOXO3 and FOXO4
transcript are undetectable in very young animals but in-
crease as animals age in the duodenum [56], and human
FOXO1 mRNA is significantly enriched in muscle sam-
ples from old individuals [57]. It will be particularly inter-
esting to determine whether the age-dependent increase
in mammalian FOXO expression are regulated at the
level of transcription, as we have shown for daf-16d/f
in C. elegans.
In worms, flies, and mammals, FOXO is the primary
target of the IIS pathway [2,58]. In C. elegans, the DAF-2
IIS receptor has been extensively studied by genetic ana-
lysis. The daf-2(e1370) allele harbors a mutation in the
tyrosine kinase domain, whereas daf-2(e1368) has a mu-
tation in the ligand-binding domain [5]. These daf-2 al-
leles show phenotypic differences, with daf-2(e1370)
displaying longer lifespan and stronger dauer arrest
compared to daf-2(1368) [41,58], indicating that the IIS
pathway is more active in daf-2(e1368) than in daf-2(e1370).
Our lifespan, dauer, and DAF-16 nuclear localization data in
these daf-2 mutants revealed that daf-16d/f and daf-16a re-
spond differently to changes in the levels of IIS. In both mu-
tant backgrounds, DAF-16a is predominantly nuclear
indicating that DAF-16a is activated to a similar level in both
daf-2 mutants. However, DAF-16d/f is nuclear only in the
daf-2(e1370) background and therefore appears to be more
active in this background. This suggests that a small de-
crease in IIS activates DAF-16a, whereas large decreases in
IIS will activate DAF-16d/f and could add another layer of
regulation by the different DAF-16 isoforms.
Using an RNAi screen, we identified the GATA factor
ELT-2 and the SWI/SNF subunit SWSN-1 as factors re-
quired for daf-16d/f expression. Our functional analysis
reveals that the intestinal GATA transcription factors,
ELT-2 and ELT-4, regulate daf-16 expression and, in
turn, longevity. Our findings are consistent with the
work of McGhee et al. [32], who identified multiple
GATA binding sites upstream of both daf-16a and daf-
16d/f and proposed that intestinal GATA factors, par-
ticularly ELT-2, might regulate the expression of daf-16.
Moreover, the promoters of many DAF-16 targets also
have GATA binding sites [32,48,59], suggesting that
ELT-2/ELT-4 may cooperate with DAF-16 to regulate
longevity genes in the intestine.
Recent studies suggest that epigenetic control of gene
expression is important for the aging process [60]. In C.
elegans, IIS-dependent and IIS-independent epigenetic
modifications have been linked to longevity [61-64]. Our
study shows that SWI/SNF regulates lifespan by promot-
ing the age-dependent activity of a FOXO gene. Import-
antly, components of the SWI/SNF complex are required
for the age-dependent upregulation of daf-16d/f but not
daf-16a. SWSN-2.1 is homologous to mammalian BAF60,a subunit known to interact with a number of transcrip-
tional activators [65,66]. BAF60, has three variants (a, b, c)
[66] and BAF60c has been shown to interact with the
GATA4 transcription factor to promote differentiation
in early mouse heart development [67]. We envision a
similar role in stimulation of daf-16d/f transcription in
the adult intestine. For example, ELT-2/ELT-4 GATA
or other transcription factor(s) together with SWSN-2.1/
BAF60 may interact with the daf-16d/f promoter during
development. At the young adult stage, an intestine-
specific developmental cue may stimulate the SWSN-2.1-
dependent recruitment of the core SWI/SNF machinery
to remodel the daf-16d/f promoter and activate daf-16d/f
transcription.
We have shown here and elsewhere [21] that daf-16a
and daf-16d/f are sensitive to changes in gene dosage.
For daf-16d/f, mRNA and protein are dramatically up-
regulated with age, whereas daf-16a mRNA only minim-
ally changes with age, and preventing the upregulation
of daf-16d/f in adults shortens lifespan. ELT-2 and ELT-4
are likely to be direct regulators of DAF-16. Indeed, mul-
tiple GATA binding sites exist upstream of both daf-16a
and daf-16d/f contain (data not shown). Based on our
finding that SWI/SNF specifically regulates the expression
of daf-16d/f but not daf-16a, we propose that SWI/SNF
modifies the activity of the daf-16d/f promoter but not the
daf-16a promoter. Taken together, and consistent with
our findings, we suggest a model where daf-16d/f plays a
more prominent role in lifespan regulation than daf-16a
(Figure 7).
C. elegans has proved to be an invaluable model sys-
tem for understanding the regulation and biological
functions of FOXO transcription factors. The mecha-
nisms that control FOXO proteins at a post-translational
level are remarkably conserved from worms to mam-
mals. Our findings indicate that transcriptional control
of daf-16/FOXO is also an essential regulatory event. As
there is increasing evidence that FOXOs are required for
human longevity [68-73], our findings will advance our
understanding of the regulation and function of DAF-
16/mammalian FOXO in aging and age-dependent dis-
eases including cancer and diabetes.
Methods
Strain maintenance
All strains were maintained and handled as described
[74]. Animals were grown on standard NGM plates at 15°C
using standard C. elegans techniques, unless otherwise
indicated. Mutants used in this study included, LGI:
daf-16(mgDf50); LGIII: daf-2(e1368, e1370); unc-119
(ed3). All transgenic worms have an unc-119(ed3) mu-
tation rescued by an unc-119+ co-transformation marker.
Transgenic strains generated and/or used in this study are
listed in Additional file 1: Table S8.
DAF-16 Targets 
Figure 7 Model of the transcriptional regulation of daf-16. daf-16d/f plays a more prominent role than daf-16a in lifespan regulation. The
thickness of the line represents the strength of regulation. ELT-2 and ELT-4 are shown as direct regulators of DAF-16. SWI/SNF is shown as the
direct regulator of DAF-16d/f and not DAF-16a.
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i) daf-2(e1368) unc-119(ed3) double mutants
Both genes map to Chromosome II but are 13 map
units apart. daf-2(e1368) males were mated to unc-119
(ed3) hermaphrodites. Approximately 20 F1 progeny
were picked onto individual plates and allowed to
produce progeny at 25°C. F2 daf-2(e1368) dauers
were selected from each plate and allowed to
recover at 15°C. From the F3 progeny, Unc worms
were selected, generating daf-2(e1368); unc-119(ed3).
ii) daf-16(mgDf50); daf-2(e1368) unc-119(ed3)mutants
daf-16(mgDf50); daf-2(e1368) males were mated to
daf-2(e1368); unc-119(ed3) hermaphrodites.
Approximately 20 F1 progeny were picked onto
individual plates and allowed to have progeny at
25°C. From the F2 progeny on each plate, Unc
Non-dauer worms were selected and tested for the
daf-16(mgDf50) mutation by PCR. Primer sequences
are listed in Additional file 1: Table S7. daf-16
(mgDf50); daf-2(e1370); unc-119(ed3) mutants were
used for microparticle bombardment [75] to generate
daf-16 isoform transgenic worms.
DNA construction for daf-16 isoform specific GFP and RNAi
To generate daf-16 isoform::gfp constructs, each cDNA
encoding daf-16a, daf-16d/f was cloned into the pGEM-T vector. The clones were then verified by sequencing.
For the daf-16a isoform promoter construct, a SalI/
BamHI fragment containing 6.0 kb upstream of daf-16a
was cloned into pPD95.75 (GFP containing plasmid). For
the daf-16d/f isoform promoter construct, a SphI/BamHI
fragment containing 4.1 kb upstream of daf-16d/f was
cloned into pPD95.75 (GFP containing plasmid). We then
generated full-length daf-16a1 cDNAs using mutagenic
primers with BamHI/SmaI restriction enzyme sites, which
were subcloned into pPD95.75 with the upstream promoter
fragment. For daf-16d/f, since we were unable to amplify
the daf-16d/f specific cDNA, we generated a construct
which could generate both DAF-16d1 and DAF-16d/f by
subcloning the 4.1 kb upstream genomic DNA next to the
5’ putative start codon of daf-16d1 cDNA in frame [21].
To allow the constructs to be compatible with ballistic
transformation, the unc-119+ gene was introduced into each
vector using PCR redirected DNA recombination method
[76]. To generate daf-16 isoform specific RNAi vector, NheI/
HindIII fragments covering isoform specific/overlapping
cDNA were cloned into L4440 vector [21]. The primers used
for the PCR analysis are listed in Additional file 1: Table S7.
RNA isolation and real-time PCR
Growing samples
To compare the expression of daf-16 isoforms in devel-
opmental stages, worms were synchronized by bleaching,
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bacteria. Worms were grown until the L1, L2, L3, and L4
stage and then harvested. To obtain aged worms, L4 stage
worms were transferred to FuDR plates with final concen-
tration of 0.1 mg/mL [77] seeded with OP50 bacteria. On
days 1, 2, 5, and 10, worms were harvested and frozen at
-80°C. To compare the expression of daf-16a in L4 stage, in
Figure 2, worms were synchronized by bleaching, followed
by L1 arrest in M9 buffer. The following day, the L1 worms
were placed on plates seeded with OP50 bacteria and fur-
ther incubated at 15°C until worms reached the L4 stage.
RNA preparation
Total RNA was isolated using acidic phenol (Sigma).
Briefly, worms were washed off the plates using ice cold
M9 buffer, followed by three additional washes. Next,
0.5 mL of AE buffer (acetic acid, EDTA), 0.1 mL of 10%
SDS, and 0.5 mL of phenol were added and the mixture
and vortexed vigorously for 1 min followed by incuba-
tion at 65°C for 4 min. The RNA was then purified by
phenol:chloroform extraction followed by ethanol pre-
cipitation. The concentration and the purity of the RNA
were determined by measuring the absorbance at 260/
280 nm. To further determine the quality of the RNA,
both the ribosomal 28 S and 18 S were visually inspected
on an agarose gel. For Figure 4A and B, total RNA was
purified from approximately 100 worms using Direct-
zolTM RNA MiniPrep kit (Zymo Research), as described
by the manufacturer. cDNA was synthesized using total
RNA and the SuperScript cDNA synthesis kit (Invitrogen,
USA). Gene expression levels were then determined by
real time PCR using the PowerSYBR® Green PCR Master
Mix and StepOnePlus Real-Time PCR System (Applied
Biosystems, USA). Relative gene expression was compared
to actin as an internal control. Primers used are listed in
Additional file 1: Table S7.
Western blots
All strains were allowed to grow at 15°C. For Additional
file 1: Figure S1, approximately 100 L4 stage worms were
collected for each of the transgenic strain in 10 to
15 mL of M9 buffer. Worms were then washed once
with M9. An equal amount of SDS containing loading
buffer was added to the worm pellets and samples were
immediately boiled to lyse the worms. Samples were
cooled, centrifuged briefly, and the supernatant was
loaded onto the gel. For the western blot analyses in
Figure 4C and D, equal amounts (10 mL) of worms were
used. For each experiment, the lysates were resolved on
a 10% polyacrylamide gel by SDS-PAGE. Proteins were
transferred to a nitrocellulose membrane and probed
with antibody against DAF-16 [78] (1:2,500 dilution).
The membrane was then reprobed with anti -α-tubulin
(1:8,000 dilution).Growth assays
All the strains were grown at 15°C and five L4s were
picked onto plates at 15°C. The plates were left undis-
turbed for 7 days and photos of each of the plates were
taken using Nikon Coolpix995 camera to compare the
growth of the strains.
Lifespan assays
All lifespan analyses were performed at 20°C. Strains were
semi-synchronized by allowing gravid adults to lay eggs
overnight and then removing the adult worms. Worms
were grown for several days until they reached the young
adult stage at 15°C. Approximately 150 young adult
worms were transferred to five freshly seeded plates con-
taining FuDR to a final concentration of 0.1 mg/mL [77].
Worms were then scored as dead or alive by tapping them
with a platinum wire every 2 to 3 days. Worms that died
from vulval bursting were censored. Day 1 of the lifespan
was when worms were transferred to the FuDR plate.
Statistical analyses were done using the standard chi-
squared-based log rank test. Lifespans were also verified
on non-FuDR NGM plates (Additional file 1: Figure S15).
DAF-16::GFP analysis
For measuring the nuclear:cytosolic ratio (Additional
file 1: Figure S2 and Figure 3), worms were grown at
15°C until they reached young adult stage. Then, worms
were mounted on glass slides in 50 mM sodium azide and
visualized using Zeiss Axioscope 2+ microscope. Fluores-
cent images were taken using OpenLab.3.1.7 software with
a Hamamatsu camera. For the quantification, only the re-
gion above intestinal cells in the pharynx was considered.
Using ImageJ software, the fluorescence was quantified by
measuring the pixel intensity in the nuclear versus cyto-
solic region. The ratio between the respective intensities
was then calculated and plotted. This was repeated twice
with approximately 14 to 15 worms in each assay.
RNAi screen
RNAi knockdown by feeding was performed essentially
as described in Timmons et al. [79] using a library of
clones representing 892 of the predicted 937 C. elegans
transcription factors (MacNeil and Walhout, unpub-
lished). Briefly, 50 μL of an overnight culture of HT115
bacteria carrying RNAi clones was used to inoculate
1 mL LB supplemented with 50 μg/mL ampicillin. Cul-
tures were grown, with shaking, for 6 h at 37°C. Bacteria
were pelleted and resuspended in 10% of the original
volume. NGM plates containing 5 mM IPTG were seeded
with concentrated bacteria and allowed to dry. Synchro-
nized L1 larvae were used to seed prepared RNAi plates.
Animals were visually examined for changes in GFP ex-
pression during the adult stage.
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